UPDATE: Drug company will give experimental drug to dying child after first saying no

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

UPDATE:  Chimerix has notified St. Jude that it will send the drug that could save 7-year-old Josh Hardy’s life. The company will send brincidofovir within the next 48 hours.

St. Jude said in a statement:

This drug is experimental and has not yet been approved by the FDA and the safety and effectiveness of the medication has not yet been established for use in children.  For this reason, it  will be administered under a new treatment protocol as approved by a committee charged with compliance to federal and institutional regulations for clinical research (IRB).  It is also important to understand that this remains a critical and complex medical situation.

St. Jude will continue to pursue state-of-the-art treatment for Josh and all of our patients.  We are grateful for the efforts of Chimerix, the FDA and many others who worked to achieve this outcome. We ask that you continue to keep Josh and his family in your thoughts.


Previous coverage (Memphis) A 7-year-old St. Jude patient in the intensive care unit battles a virus destroying his heart and kidney.

There’s medicine that will likely cure Josh Hardy, but until Tuesday the drug company refused to give it to him, saying that helping Josh would hurt others.

Since Josh was 9 months old, he has beat cancer four times.

When he got a bone marrow transplant last year, Josh faced another battle – he caught an adenovirus that spread through his body.

“He had the bone marrow cells administered January 10. On January 14, we went to the ICU, and we have been there since. He had heart failure, kidney failure and major lung issues,” said his mom Aimee, who remains strong and continues to pray for a miracle.

Aimee Hardy said there’s only one experimental drug that’s not approved by the FDA that can likely save him, and St. Jude doctors have requested it several times. The North Carolina drug company, Chimerix, won’t give it to him saying if they help Josh, they won’t be able to get the drug to market in 2016 and save more lives.

“They have the opportunity to be a real life superhero for a little 7-year-old, and they’re not they are focused on going to market,” said Aimee Hardy.

She said Josh is depressed and worried what’s to come. The only thing he’s looking forward to is his eighth birthday on March 31st.

Read more on Josh’s story. 

For more information: https://www.facebook.com/SaveJoshHardy

The family also started a petition on change.org: http://www.change.org/petitions/chimerix-release-brincidofovir-for-compassionate-use-to-treat-the-adenovirus-plaguing-7-year-old-josh-hardy-right-now

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.